SECURITY

Natco Pharma Limited

Natco Pharma Limited: 34 reported NSE/BSE deal sides from 2017-06-28 to 2025-11-26.

Reported purchases₹597.46 Cr

Reported sales₹625.83 Cr

Disclosed sides34

Recent disclosures

Date	Company	Participant	Side	Shares	Price	Reported value
2025-11-26NSE · Bulk	Natco Pharma Limited	GRAVITON RESEARCH CAPITAL LLP	Sell	1,199,411	₹904.93	₹108.54 Cr
2025-11-26NSE · Bulk	Natco Pharma Limited	GRAVITON RESEARCH CAPITAL LLP	Buy	1,199,044	₹904.19	₹108.42 Cr
2025-04-24NSE · Bulk	Natco Pharma Limited	GRAVITON RESEARCH CAPITAL LLP	Sell	1,784,917	₹930.19	₹166.03 Cr
2025-04-24NSE · Bulk	Natco Pharma Limited	GRAVITON RESEARCH CAPITAL LLP	Buy	1,784,917	₹929.71	₹165.95 Cr
2025-02-14NSE · Bulk	Natco Pharma Limited	GRAVITON RESEARCH CAPITAL LLP	Sell	971,727	₹891.03	₹86.58 Cr
2025-02-14NSE · Bulk	Natco Pharma Limited	GRAVITON RESEARCH CAPITAL LLP	Buy	971,727	₹890.86	₹86.57 Cr
2024-02-21BSE · Block	Natco Pharma Limited	THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT	Buy	198,742	₹1039.15	₹20.65 Cr
2024-02-21BSE · Block	Natco Pharma Limited	JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITED	Sell	198,742	₹1039.15	₹20.65 Cr
2024-01-25BSE · Block	Natco Pharma Limited	SOCIETE GENERALE	Buy	662,733	₹859.20	₹56.94 Cr
2024-01-25BSE · Block	Natco Pharma Limited	BNP PARIBAS ARBITRAGE	Sell	662,733	₹859.20	₹56.94 Cr
2024-01-25BSE · Block	Natco Pharma Limited	MARSHALLWACEINVESTMENTSTRATEGIESMARKETNEUTRALTOPSFUND	Buy	149,926	₹859.20	₹12.88 Cr
2024-01-25BSE · Block	Natco Pharma Limited	BNP PARIBAS ARBITRAGE	Sell	149,926	₹859.20	₹12.88 Cr
2022-10-25BSE · Block	Natco Pharma Limited	ISHARES CORE EMERGING MARKETS MAURITIUS CO	Sell	193,938	₹593.90	₹11.52 Cr
2022-10-25BSE · Block	Natco Pharma Limited	ISHARES CORE MSCI EMERGING MARKETS ETF	Buy	193,938	₹593.90	₹11.52 Cr
2022-10-25BSE · Block	Natco Pharma Limited	ISHARES MSCI INDIA SMALL-CAP ETF	Buy	22,874	₹593.90	₹1.36 Cr